nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—GLYATL1—renal system—colon cancer	0.0156	0.0355	CbGeAlD
Glycine—BAAT—liver—colon cancer	0.0148	0.0337	CbGeAlD
Glycine—GLYAT—renal system—colon cancer	0.0147	0.0334	CbGeAlD
Glycine—Toxicity to various agents—Irinotecan—colon cancer	0.0146	0.0695	CcSEcCtD
Glycine—SHMT1—Vinblastine—Vincristine—colon cancer	0.0122	1	CbGdCrCtD
Glycine—Blindness transient—Methotrexate—colon cancer	0.0114	0.0542	CcSEcCtD
Glycine—Salivation—Irinotecan—colon cancer	0.0108	0.0513	CcSEcCtD
Glycine—AGXT—renal system—colon cancer	0.0101	0.0229	CbGeAlD
Glycine—GLYATL2—bone marrow—colon cancer	0.01	0.0228	CbGeAlD
Glycine—Electrolyte imbalance—Irinotecan—colon cancer	0.01	0.0476	CcSEcCtD
Glycine—GCSH—renal system—colon cancer	0.00964	0.0219	CbGeAlD
Glycine—GLYATL1—liver—colon cancer	0.00954	0.0217	CbGeAlD
Glycine—GLYAT—liver—colon cancer	0.00897	0.0204	CbGeAlD
Glycine—AGXT2—renal system—colon cancer	0.00855	0.0194	CbGeAlD
Glycine—GPR18—lymphoid tissue—colon cancer	0.00854	0.0194	CbGeAlD
Glycine—ALAS2—bone marrow—colon cancer	0.00841	0.0191	CbGeAlD
Glycine—GLRA2—renal system—colon cancer	0.0082	0.0186	CbGeAlD
Glycine—GLDC—renal system—colon cancer	0.00799	0.0182	CbGeAlD
Glycine—GPR18—bone marrow—colon cancer	0.00778	0.0177	CbGeAlD
Glycine—GARS—embryo—colon cancer	0.00763	0.0174	CbGeAlD
Glycine—PIPOX—renal system—colon cancer	0.00746	0.017	CbGeAlD
Glycine—GPR18—vagina—colon cancer	0.00745	0.0169	CbGeAlD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—ODC1—colon cancer	0.00742	0.022	CbGpPWpGaD
Glycine—ALAS1—FOXA2 and FOXA3 transcription factor networks—HNF4A—colon cancer	0.00701	0.0208	CbGpPWpGaD
Glycine—ALAS2—liver—colon cancer	0.0068	0.0155	CbGeAlD
Glycine—SHMT2—Trans-sulfuration and one carbon metabolism—TYMS—colon cancer	0.00673	0.0199	CbGpPWpGaD
Glycine—GLYAT—Metapathway biotransformation—CHST5—colon cancer	0.00666	0.0197	CbGpPWpGaD
Glycine—GLYATL1—Metapathway biotransformation—CHST5—colon cancer	0.00666	0.0197	CbGpPWpGaD
Glycine—GLYATL2—Metapathway biotransformation—CHST5—colon cancer	0.00666	0.0197	CbGpPWpGaD
Glycine—BAAT—Metapathway biotransformation—CHST5—colon cancer	0.00635	0.0188	CbGpPWpGaD
Glycine—ALAS1—renal system—colon cancer	0.00634	0.0144	CbGeAlD
Glycine—GATM—Amino acid and derivative metabolism—ODC1—colon cancer	0.00629	0.0186	CbGpPWpGaD
Glycine—Encephalopathy—Fluorouracil—colon cancer	0.00624	0.0297	CcSEcCtD
Glycine—AGXT—liver—colon cancer	0.00615	0.014	CbGeAlD
Glycine—AGXT2—Pyrimidine metabolism—TYMS—colon cancer	0.00612	0.0181	CbGpPWpGaD
Glycine—GARS—smooth muscle tissue—colon cancer	0.006	0.0136	CbGeAlD
Glycine—Lung disorder—Irinotecan—colon cancer	0.00591	0.0281	CcSEcCtD
Glycine—GCSH—liver—colon cancer	0.00589	0.0134	CbGeAlD
Glycine—GLDC—vagina—colon cancer	0.00579	0.0132	CbGeAlD
Glycine—GARS—renal system—colon cancer	0.00578	0.0131	CbGeAlD
Glycine—ALAS1—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.00564	0.0167	CbGpPWpGaD
Glycine—SLC6A9—lymph node—colon cancer	0.00554	0.0126	CbGeAlD
Glycine—GATM—renal system—colon cancer	0.00548	0.0125	CbGeAlD
Glycine—GCAT—bone marrow—colon cancer	0.00547	0.0124	CbGeAlD
Glycine—PIPOX—vagina—colon cancer	0.0054	0.0123	CbGeAlD
Glycine—AGXT—Amino acid and derivative metabolism—ODC1—colon cancer	0.00535	0.0158	CbGpPWpGaD
Glycine—GCAT—vagina—colon cancer	0.00524	0.0119	CbGeAlD
Glycine—AGXT2—liver—colon cancer	0.00523	0.0119	CbGeAlD
Glycine—ALAS1—digestive system—colon cancer	0.0052	0.0118	CbGeAlD
Glycine—GNMT—liver—colon cancer	0.00515	0.0117	CbGeAlD
Glycine—SHMT2—renal system—colon cancer	0.00503	0.0114	CbGeAlD
Glycine—GLDC—liver—colon cancer	0.00488	0.0111	CbGeAlD
Glycine—GPR18—lymph node—colon cancer	0.00482	0.011	CbGeAlD
Glycine—GARS—lymphoid tissue—colon cancer	0.0048	0.0109	CbGeAlD
Glycine—ALAS1—bone marrow—colon cancer	0.0048	0.0109	CbGeAlD
Glycine—GARS—digestive system—colon cancer	0.00474	0.0108	CbGeAlD
Glycine—ALAS1—vagina—colon cancer	0.00459	0.0104	CbGeAlD
Glycine—SHMT1—renal system—colon cancer	0.00457	0.0104	CbGeAlD
Glycine—PIPOX—liver—colon cancer	0.00456	0.0104	CbGeAlD
Glycine—AGXT2—Amino acid and derivative metabolism—ODC1—colon cancer	0.00455	0.0135	CbGpPWpGaD
Glycine—GCSH—lymph node—colon cancer	0.00452	0.0103	CbGeAlD
Glycine—GATM—digestive system—colon cancer	0.0045	0.0102	CbGeAlD
Glycine—GCAT—liver—colon cancer	0.00442	0.0101	CbGeAlD
Glycine—SHMT1—One Carbon Metabolism—TYMS—colon cancer	0.00441	0.0131	CbGpPWpGaD
Glycine—GARS—bone marrow—colon cancer	0.00437	0.00993	CbGeAlD
Glycine—Encephalopathy—Capecitabine—colon cancer	0.00436	0.0207	CcSEcCtD
Glycine—GARS—vagina—colon cancer	0.00418	0.00951	CbGeAlD
Glycine—SHMT2—lymphoid tissue—colon cancer	0.00417	0.00949	CbGeAlD
Glycine—SHMT2—digestive system—colon cancer	0.00412	0.00937	CbGeAlD
Glycine—Salivary hypersecretion—Irinotecan—colon cancer	0.00406	0.0193	CcSEcCtD
Glycine—GATM—vagina—colon cancer	0.00397	0.00903	CbGeAlD
Glycine—SHMT1—Trans-sulfuration and one carbon metabolism—TYMS—colon cancer	0.00397	0.0117	CbGpPWpGaD
Glycine—Coma—Vincristine—colon cancer	0.00393	0.0186	CcSEcCtD
Glycine—SLC36A1—renal system—colon cancer	0.0039	0.00887	CbGeAlD
Glycine—ALAS1—liver—colon cancer	0.00388	0.00881	CbGeAlD
Glycine—GSS—Trans-sulfuration and one carbon metabolism—TYMS—colon cancer	0.00386	0.0114	CbGpPWpGaD
Glycine—GSS—Metapathway biotransformation—CHST5—colon cancer	0.00382	0.0113	CbGpPWpGaD
Glycine—SHMT2—bone marrow—colon cancer	0.0038	0.00864	CbGeAlD
Glycine—SHMT1—lymphoid tissue—colon cancer	0.0038	0.00864	CbGeAlD
Glycine—SHMT1—digestive system—colon cancer	0.00375	0.00853	CbGeAlD
Glycine—GLDC—lymph node—colon cancer	0.00374	0.00851	CbGeAlD
Glycine—SHMT1—Amino acid and derivative metabolism—ODC1—colon cancer	0.00371	0.011	CbGpPWpGaD
Glycine—Coma—Fluorouracil—colon cancer	0.00366	0.0174	CcSEcCtD
Glycine—SHMT2—vagina—colon cancer	0.00364	0.00828	CbGeAlD
Glycine—GSS—smooth muscle tissue—colon cancer	0.00357	0.00812	CbGeAlD
Glycine—Polyuria—Vincristine—colon cancer	0.00355	0.0169	CcSEcCtD
Glycine—GARS—liver—colon cancer	0.00353	0.00803	CbGeAlD
Glycine—Thrombophlebitis—Irinotecan—colon cancer	0.00351	0.0167	CcSEcCtD
Glycine—SHMT1—bone marrow—colon cancer	0.00346	0.00787	CbGeAlD
Glycine—GSS—renal system—colon cancer	0.00344	0.00781	CbGeAlD
Glycine—GLRB—vagina—colon cancer	0.00341	0.00776	CbGeAlD
Glycine—GCAT—lymph node—colon cancer	0.00339	0.00771	CbGeAlD
Glycine—Thrombophlebitis—Fluorouracil—colon cancer	0.00336	0.016	CcSEcCtD
Glycine—GATM—liver—colon cancer	0.00335	0.00762	CbGeAlD
Glycine—SHMT1—vagina—colon cancer	0.00331	0.00754	CbGeAlD
Glycine—Encephalopathy—Methotrexate—colon cancer	0.00325	0.0154	CcSEcCtD
Glycine—Visual disturbance—Irinotecan—colon cancer	0.0032	0.0152	CcSEcCtD
Glycine—SLC36A1—digestive system—colon cancer	0.0032	0.00728	CbGeAlD
Glycine—Hyponatraemia—Vincristine—colon cancer	0.00313	0.0149	CcSEcCtD
Glycine—SHMT2—liver—colon cancer	0.00307	0.00698	CbGeAlD
Glycine—Hyponatraemia—Irinotecan—colon cancer	0.00305	0.0145	CcSEcCtD
Glycine—ALAS1—lymph node—colon cancer	0.00297	0.00676	CbGeAlD
Glycine—Urinary retention—Vincristine—colon cancer	0.00297	0.0141	CcSEcCtD
Glycine—SLC36A1—bone marrow—colon cancer	0.00295	0.00671	CbGeAlD
Glycine—Lung disorder—Methotrexate—colon cancer	0.00294	0.014	CcSEcCtD
Glycine—Dehydration—Vincristine—colon cancer	0.0029	0.0138	CcSEcCtD
Glycine—GRIN2A—vagina—colon cancer	0.00284	0.00647	CbGeAlD
Glycine—SLC36A1—vagina—colon cancer	0.00283	0.00643	CbGeAlD
Glycine—Dehydration—Irinotecan—colon cancer	0.00282	0.0134	CcSEcCtD
Glycine—GSS—digestive system—colon cancer	0.00282	0.00641	CbGeAlD
Glycine—SHMT1—liver—colon cancer	0.0028	0.00636	CbGeAlD
Glycine—SLC16A10—epithelium—colon cancer	0.00271	0.00617	CbGeAlD
Glycine—GARS—lymph node—colon cancer	0.00271	0.00615	CbGeAlD
Glycine—GSS—bone marrow—colon cancer	0.0026	0.00591	CbGeAlD
Glycine—GATM—lymph node—colon cancer	0.00257	0.00584	CbGeAlD
Glycine—Angina pectoris—Irinotecan—colon cancer	0.00256	0.0121	CcSEcCtD
Glycine—ALAS2—Metabolism—CA7—colon cancer	0.00251	0.00745	CbGpPWpGaD
Glycine—GSS—vagina—colon cancer	0.00249	0.00566	CbGeAlD
Glycine—Angina pectoris—Fluorouracil—colon cancer	0.00245	0.0116	CcSEcCtD
Glycine—AGXT2—Nucleotide metabolism—TYMS—colon cancer	0.00239	0.00707	CbGpPWpGaD
Glycine—SLC36A1—liver—colon cancer	0.00238	0.00542	CbGeAlD
Glycine—SHMT2—lymph node—colon cancer	0.00235	0.00535	CbGeAlD
Glycine—Thrombophlebitis—Capecitabine—colon cancer	0.00235	0.0112	CcSEcCtD
Glycine—GRIN2C—CREB phosphorylation through the activation of Ras—BRAF—colon cancer	0.00232	0.00688	CbGpPWpGaD
Glycine—Polyuria—Capecitabine—colon cancer	0.00231	0.011	CcSEcCtD
Glycine—GLRB—lymph node—colon cancer	0.00221	0.00502	CbGeAlD
Glycine—SHMT1—lymph node—colon cancer	0.00214	0.00487	CbGeAlD
Glycine—Thirst—Capecitabine—colon cancer	0.00214	0.0101	CcSEcCtD
Glycine—Rhinitis—Irinotecan—colon cancer	0.00211	0.01	CcSEcCtD
Glycine—GSS—liver—colon cancer	0.0021	0.00477	CbGeAlD
Glycine—SLC16A10—lymphoid tissue—colon cancer	0.00209	0.00475	CbGeAlD
Glycine—Hyponatraemia—Capecitabine—colon cancer	0.00204	0.00969	CcSEcCtD
Glycine—Visual impairment—Irinotecan—colon cancer	0.00202	0.00962	CcSEcCtD
Glycine—Rhinitis—Fluorouracil—colon cancer	0.00202	0.00958	CcSEcCtD
Glycine—Urinary retention—Capecitabine—colon cancer	0.00193	0.00918	CcSEcCtD
Glycine—GRIN2C—Post NMDA receptor activation events—BRAF—colon cancer	0.00191	0.00566	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CA7—colon cancer	0.00191	0.00565	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CA7—colon cancer	0.00191	0.00565	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CA7—colon cancer	0.00191	0.00565	CbGpPWpGaD
Glycine—GATM—Metabolism—CA7—colon cancer	0.00191	0.00565	CbGpPWpGaD
Glycine—Coma—Methotrexate—colon cancer	0.0019	0.00905	CcSEcCtD
Glycine—Dehydration—Capecitabine—colon cancer	0.00189	0.00898	CcSEcCtD
Glycine—Chills—Irinotecan—colon cancer	0.00189	0.00895	CcSEcCtD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—BAX—colon cancer	0.00185	0.00549	CbGpPWpGaD
Glycine—SLC36A1—lymph node—colon cancer	0.00183	0.00416	CbGeAlD
Glycine—SLC16A10—vagina—colon cancer	0.00182	0.00414	CbGeAlD
Glycine—BAAT—Metabolism—CA7—colon cancer	0.00182	0.00539	CbGpPWpGaD
Glycine—Back pain—Vincristine—colon cancer	0.00182	0.00863	CcSEcCtD
Glycine—GRIN2A—CREB phosphorylation through the activation of Ras—BRAF—colon cancer	0.00177	0.00525	CbGpPWpGaD
Glycine—Back pain—Irinotecan—colon cancer	0.00177	0.0084	CcSEcCtD
Glycine—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—colon cancer	0.00176	0.00522	CbGpPWpGaD
Glycine—Thrombophlebitis—Methotrexate—colon cancer	0.00175	0.0083	CcSEcCtD
Glycine—Polyuria—Methotrexate—colon cancer	0.00172	0.00819	CcSEcCtD
Glycine—Angina pectoris—Capecitabine—colon cancer	0.00171	0.00813	CcSEcCtD
Glycine—Vertigo—Vincristine—colon cancer	0.00169	0.00801	CcSEcCtD
Glycine—Vision blurred—Fluorouracil—colon cancer	0.00165	0.00784	CcSEcCtD
Glycine—Vertigo—Irinotecan—colon cancer	0.00164	0.00781	CcSEcCtD
Glycine—Convulsion—Vincristine—colon cancer	0.00163	0.00773	CcSEcCtD
Glycine—AGXT—Metabolism—CA7—colon cancer	0.00162	0.0048	CbGpPWpGaD
Glycine—GSS—lymph node—colon cancer	0.00161	0.00366	CbGeAlD
Glycine—Visual disturbance—Methotrexate—colon cancer	0.0016	0.00758	CcSEcCtD
Glycine—ALAS1—Metabolism—CA7—colon cancer	0.00157	0.00465	CbGpPWpGaD
Glycine—SLC16A10—liver—colon cancer	0.00154	0.0035	CbGeAlD
Glycine—Oedema—Vincristine—colon cancer	0.00153	0.00728	CcSEcCtD
Glycine—ALAS2—Metabolism—CHST5—colon cancer	0.00152	0.00451	CbGpPWpGaD
Glycine—ALAS2—Metabolism—ODC1—colon cancer	0.00152	0.00451	CbGpPWpGaD
Glycine—Convulsion—Fluorouracil—colon cancer	0.00152	0.00721	CcSEcCtD
Glycine—GRIN2C—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—colon cancer	0.0015	0.00444	CbGpPWpGaD
Glycine—Oedema—Irinotecan—colon cancer	0.00149	0.00709	CcSEcCtD
Glycine—ALAS1—PPARA activates gene expression—PPARG—colon cancer	0.00146	0.00433	CbGpPWpGaD
Glycine—GRIN2A—Post NMDA receptor activation events—BRAF—colon cancer	0.00146	0.00432	CbGpPWpGaD
Glycine—Hypotension—Vincristine—colon cancer	0.00143	0.0068	CcSEcCtD
Glycine—ALAS1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	0.00143	0.00424	CbGpPWpGaD
Glycine—Oedema—Fluorouracil—colon cancer	0.00143	0.00679	CcSEcCtD
Glycine—Rhinitis—Capecitabine—colon cancer	0.00141	0.0067	CcSEcCtD
Glycine—Tachycardia—Fluorouracil—colon cancer	0.0014	0.00663	CcSEcCtD
Glycine—Hypotension—Irinotecan—colon cancer	0.00139	0.00663	CcSEcCtD
Glycine—AGXT2—Metabolism—CA7—colon cancer	0.00138	0.00408	CbGpPWpGaD
Glycine—Visual impairment—Capecitabine—colon cancer	0.00136	0.00644	CcSEcCtD
Glycine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—colon cancer	0.00134	0.00398	CbGpPWpGaD
Glycine—Hypotension—Fluorouracil—colon cancer	0.00134	0.00635	CcSEcCtD
Glycine—Pain—Vincristine—colon cancer	0.00131	0.00623	CcSEcCtD
Glycine—Pain—Irinotecan—colon cancer	0.00128	0.00606	CcSEcCtD
Glycine—Chills—Capecitabine—colon cancer	0.00126	0.00599	CcSEcCtD
Glycine—SHMT2—Folate Metabolism—TP53—colon cancer	0.00125	0.0037	CbGpPWpGaD
Glycine—Pain—Fluorouracil—colon cancer	0.00122	0.00581	CcSEcCtD
Glycine—ALAS1—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	0.0012	0.00356	CbGpPWpGaD
Glycine—Back pain—Capecitabine—colon cancer	0.00118	0.00562	CcSEcCtD
Glycine—SLC16A10—lymph node—colon cancer	0.00118	0.00268	CbGeAlD
Glycine—GLYAT—Metabolism—ODC1—colon cancer	0.00115	0.00342	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CHST5—colon cancer	0.00115	0.00342	CbGpPWpGaD
Glycine—GATM—Metabolism—ODC1—colon cancer	0.00115	0.00342	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CHST5—colon cancer	0.00115	0.00342	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CHST5—colon cancer	0.00115	0.00342	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ODC1—colon cancer	0.00115	0.00342	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ODC1—colon cancer	0.00115	0.00342	CbGpPWpGaD
Glycine—GATM—Metabolism—CHST5—colon cancer	0.00115	0.00342	CbGpPWpGaD
Glycine—Vision blurred—Capecitabine—colon cancer	0.00115	0.00548	CcSEcCtD
Glycine—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—colon cancer	0.00114	0.00339	CbGpPWpGaD
Glycine—Urticaria—Fluorouracil—colon cancer	0.00114	0.00539	CcSEcCtD
Glycine—Hypersensitivity—Vincristine—colon cancer	0.00113	0.00536	CcSEcCtD
Glycine—SHMT1—Metabolism—CA7—colon cancer	0.00112	0.00333	CbGpPWpGaD
Glycine—BAAT—Metabolism—ODC1—colon cancer	0.0011	0.00326	CbGpPWpGaD
Glycine—BAAT—Metabolism—CHST5—colon cancer	0.0011	0.00326	CbGpPWpGaD
Glycine—Vertigo—Capecitabine—colon cancer	0.0011	0.00522	CcSEcCtD
Glycine—Hypersensitivity—Irinotecan—colon cancer	0.0011	0.00522	CcSEcCtD
Glycine—GSS—Metabolism—CA7—colon cancer	0.00109	0.00324	CbGpPWpGaD
Glycine—GRIN2C—CREB phosphorylation through the activation of Ras—HRAS—colon cancer	0.00107	0.00316	CbGpPWpGaD
Glycine—Hypersensitivity—Fluorouracil—colon cancer	0.00105	0.005	CcSEcCtD
Glycine—Diarrhoea—Vincristine—colon cancer	0.00105	0.00498	CcSEcCtD
Glycine—GPR18—Signaling Pathways—DLC1—colon cancer	0.00103	0.00304	CbGpPWpGaD
Glycine—SLC32A1—Transmission across Chemical Synapses—BRAF—colon cancer	0.00102	0.00303	CbGpPWpGaD
Glycine—Diarrhoea—Irinotecan—colon cancer	0.00102	0.00485	CcSEcCtD
Glycine—Dizziness—Vincristine—colon cancer	0.00101	0.00481	CcSEcCtD
Glycine—Visual impairment—Methotrexate—colon cancer	0.00101	0.00479	CcSEcCtD
Glycine—Oedema—Capecitabine—colon cancer	0.000999	0.00475	CcSEcCtD
Glycine—SHMT1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—colon cancer	0.000993	0.00294	CbGpPWpGaD
Glycine—Dizziness—Irinotecan—colon cancer	0.000987	0.00469	CcSEcCtD
Glycine—ALAS1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	0.000986	0.00292	CbGpPWpGaD
Glycine—AGXT—Metabolism—CHST5—colon cancer	0.000982	0.00291	CbGpPWpGaD
Glycine—AGXT—Metabolism—ODC1—colon cancer	0.000982	0.00291	CbGpPWpGaD
Glycine—Diarrhoea—Fluorouracil—colon cancer	0.000978	0.00465	CcSEcCtD
Glycine—Tachycardia—Capecitabine—colon cancer	0.000975	0.00463	CcSEcCtD
Glycine—Vomiting—Vincristine—colon cancer	0.000974	0.00463	CcSEcCtD
Glycine—GPR18—Signaling Pathways—LGR5—colon cancer	0.000966	0.00286	CbGpPWpGaD
Glycine—ALAS1—PPARA activates gene expression—EP300—colon cancer	0.000956	0.00283	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CHST5—colon cancer	0.000951	0.00282	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ODC1—colon cancer	0.000951	0.00282	CbGpPWpGaD
Glycine—Vomiting—Irinotecan—colon cancer	0.000949	0.00451	CcSEcCtD
Glycine—Dizziness—Fluorouracil—colon cancer	0.000945	0.00449	CcSEcCtD
Glycine—Chills—Methotrexate—colon cancer	0.000939	0.00446	CcSEcCtD
Glycine—ALAS1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	0.000936	0.00277	CbGpPWpGaD
Glycine—Hypotension—Capecitabine—colon cancer	0.000933	0.00443	CcSEcCtD
Glycine—Nausea—Vincristine—colon cancer	0.00091	0.00432	CcSEcCtD
Glycine—Vomiting—Fluorouracil—colon cancer	0.000909	0.00432	CcSEcCtD
Glycine—GRIN2A—Reelin signaling pathway—PIK3CA—colon cancer	0.000906	0.00269	CbGpPWpGaD
Glycine—SLC6A9—NRF2 pathway—TGFB1—colon cancer	0.000903	0.00268	CbGpPWpGaD
Glycine—SLC6A5—NRF2 pathway—TGFB1—colon cancer	0.000903	0.00268	CbGpPWpGaD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—EP300—colon cancer	0.000892	0.00264	CbGpPWpGaD
Glycine—Nausea—Irinotecan—colon cancer	0.000887	0.00421	CcSEcCtD
Glycine—Back pain—Methotrexate—colon cancer	0.000881	0.00419	CcSEcCtD
Glycine—GRIN2C—Post NMDA receptor activation events—HRAS—colon cancer	0.000879	0.0026	CbGpPWpGaD
Glycine—Vision blurred—Methotrexate—colon cancer	0.000859	0.00408	CcSEcCtD
Glycine—Pain—Capecitabine—colon cancer	0.000854	0.00406	CcSEcCtD
Glycine—Nausea—Fluorouracil—colon cancer	0.000849	0.00403	CcSEcCtD
Glycine—AGXT2—Metabolism—ODC1—colon cancer	0.000835	0.00247	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CHST5—colon cancer	0.000835	0.00247	CbGpPWpGaD
Glycine—GARS—Gene Expression—HNF4A—colon cancer	0.00083	0.00246	CbGpPWpGaD
Glycine—Vertigo—Methotrexate—colon cancer	0.000819	0.00389	CcSEcCtD
Glycine—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—colon cancer	0.000815	0.00242	CbGpPWpGaD
Glycine—SHMT1—Disease—LGR5—colon cancer	0.000813	0.00241	CbGpPWpGaD
Glycine—SHMT1—Disease—CHST5—colon cancer	0.000813	0.00241	CbGpPWpGaD
Glycine—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—colon cancer	0.00081	0.0024	CbGpPWpGaD
Glycine—Urticaria—Capecitabine—colon cancer	0.000794	0.00377	CcSEcCtD
Glycine—Convulsion—Methotrexate—colon cancer	0.000789	0.00375	CcSEcCtD
Glycine—SLC32A1—Neuronal System—BRAF—colon cancer	0.000783	0.00232	CbGpPWpGaD
Glycine—GRIN2C—Alzheimers Disease—CASP3—colon cancer	0.000781	0.00231	CbGpPWpGaD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—MYC—colon cancer	0.000777	0.0023	CbGpPWpGaD
Glycine—GRIN2A—Reelin signaling pathway—AKT1—colon cancer	0.00074	0.00219	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—TP53—colon cancer	0.000737	0.00218	CbGpPWpGaD
Glycine—Hypersensitivity—Capecitabine—colon cancer	0.000736	0.0035	CcSEcCtD
Glycine—SLC6A9—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000731	0.00217	CbGpPWpGaD
Glycine—SLC6A5—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000731	0.00217	CbGpPWpGaD
Glycine—Hypotension—Methotrexate—colon cancer	0.000695	0.0033	CcSEcCtD
Glycine—GPR18—Signaling Pathways—AXIN2—colon cancer	0.000694	0.00206	CbGpPWpGaD
Glycine—Diarrhoea—Capecitabine—colon cancer	0.000684	0.00325	CcSEcCtD
Glycine—SHMT1—Metabolism—ODC1—colon cancer	0.000681	0.00202	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CHST5—colon cancer	0.000681	0.00202	CbGpPWpGaD
Glycine—GRIN2A—Post NMDA receptor activation events—HRAS—colon cancer	0.000671	0.00199	CbGpPWpGaD
Glycine—GSS—Metabolism—ODC1—colon cancer	0.000663	0.00196	CbGpPWpGaD
Glycine—GSS—Metabolism—CHST5—colon cancer	0.000663	0.00196	CbGpPWpGaD
Glycine—Dizziness—Capecitabine—colon cancer	0.000661	0.00314	CcSEcCtD
Glycine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—colon cancer	0.000659	0.00195	CbGpPWpGaD
Glycine—ALAS1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	0.000645	0.00191	CbGpPWpGaD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—TP53—colon cancer	0.000638	0.00189	CbGpPWpGaD
Glycine—Pain—Methotrexate—colon cancer	0.000636	0.00302	CcSEcCtD
Glycine—Vomiting—Capecitabine—colon cancer	0.000635	0.00302	CcSEcCtD
Glycine—SLC32A1—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000622	0.00184	CbGpPWpGaD
Glycine—GLRA2—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000622	0.00184	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000622	0.00184	CbGpPWpGaD
Glycine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—colon cancer	0.000618	0.00183	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—CASP3—colon cancer	0.000596	0.00177	CbGpPWpGaD
Glycine—Nausea—Capecitabine—colon cancer	0.000593	0.00282	CcSEcCtD
Glycine—Urticaria—Methotrexate—colon cancer	0.000591	0.00281	CcSEcCtD
Glycine—SHMT1—Disease—AXIN2—colon cancer	0.000584	0.00173	CbGpPWpGaD
Glycine—Hypersensitivity—Methotrexate—colon cancer	0.000548	0.0026	CcSEcCtD
Glycine—Diarrhoea—Methotrexate—colon cancer	0.000509	0.00242	CcSEcCtD
Glycine—GLRB—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000507	0.0015	CbGpPWpGaD
Glycine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—colon cancer	0.000503	0.00149	CbGpPWpGaD
Glycine—GRIN2C—Alzheimers Disease—TP53—colon cancer	0.000501	0.00148	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—BRAF—colon cancer	0.000496	0.00147	CbGpPWpGaD
Glycine—Dizziness—Methotrexate—colon cancer	0.000492	0.00234	CcSEcCtD
Glycine—Vomiting—Methotrexate—colon cancer	0.000473	0.00225	CcSEcCtD
Glycine—SLC32A1—Transmission across Chemical Synapses—HRAS—colon cancer	0.00047	0.00139	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000455	0.00135	CbGpPWpGaD
Glycine—Nausea—Methotrexate—colon cancer	0.000442	0.0021	CcSEcCtD
Glycine—ALAS2—Metabolism—ABCB1—colon cancer	0.000403	0.00119	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—ABCB1—colon cancer	0.0004	0.00119	CbGpPWpGaD
Glycine—ALAS2—Metabolism—TYMS—colon cancer	0.000395	0.00117	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000393	0.00116	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—TP53—colon cancer	0.000382	0.00113	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—BRAF—colon cancer	0.00038	0.00112	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—BRAF—colon cancer	0.000378	0.00112	CbGpPWpGaD
Glycine—GARS—Gene Expression—PPARG—colon cancer	0.00036	0.00107	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—HRAS—colon cancer	0.00036	0.00107	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000358	0.00106	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000357	0.00106	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000309	0.000915	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ABCB1—colon cancer	0.000305	0.000904	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ABCB1—colon cancer	0.000305	0.000904	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ABCB1—colon cancer	0.000305	0.000904	CbGpPWpGaD
Glycine—GATM—Metabolism—ABCB1—colon cancer	0.000305	0.000904	CbGpPWpGaD
Glycine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	0.000303	0.000898	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—TYMS—colon cancer	0.0003	0.000888	CbGpPWpGaD
Glycine—GATM—Metabolism—TYMS—colon cancer	0.0003	0.000888	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—TYMS—colon cancer	0.0003	0.000888	CbGpPWpGaD
Glycine—GLYAT—Metabolism—TYMS—colon cancer	0.0003	0.000888	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000298	0.000881	CbGpPWpGaD
Glycine—BAAT—Metabolism—ABCB1—colon cancer	0.000291	0.000862	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—BRAF—colon cancer	0.00029	0.000859	CbGpPWpGaD
Glycine—BAAT—Metabolism—TYMS—colon cancer	0.000286	0.000847	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PPARG—colon cancer	0.00028	0.00083	CbGpPWpGaD
Glycine—AGXT—Metabolism—ABCB1—colon cancer	0.000259	0.000769	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000257	0.000761	CbGpPWpGaD
Glycine—AGXT—Metabolism—TYMS—colon cancer	0.000255	0.000755	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ABCB1—colon cancer	0.000251	0.000744	CbGpPWpGaD
Glycine—ALAS1—Metabolism—TYMS—colon cancer	0.000247	0.000731	CbGpPWpGaD
Glycine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	0.000231	0.000685	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—HRAS—colon cancer	0.000228	0.000675	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ABCB1—colon cancer	0.000221	0.000654	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PTGS2—colon cancer	0.00022	0.000653	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.00022	0.000652	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000217	0.000643	CbGpPWpGaD
Glycine—AGXT2—Metabolism—TYMS—colon cancer	0.000217	0.000642	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PPARG—colon cancer	0.000212	0.000629	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PPARG—colon cancer	0.000212	0.000629	CbGpPWpGaD
Glycine—GATM—Metabolism—PPARG—colon cancer	0.000212	0.000629	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PPARG—colon cancer	0.000212	0.000629	CbGpPWpGaD
Glycine—GARS—Gene Expression—MYC—colon cancer	0.000205	0.000608	CbGpPWpGaD
Glycine—BAAT—Metabolism—PPARG—colon cancer	0.000203	0.0006	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FGFR3—colon cancer	0.0002	0.000593	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.00019	0.000563	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—APC—colon cancer	0.000184	0.000545	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—NRAS—colon cancer	0.000184	0.000545	CbGpPWpGaD
Glycine—ALAS2—Metabolism—EP300—colon cancer	0.000183	0.000543	CbGpPWpGaD
Glycine—AGXT—Metabolism—PPARG—colon cancer	0.000181	0.000535	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ABCB1—colon cancer	0.00018	0.000533	CbGpPWpGaD
Glycine—SHMT1—Metabolism—TYMS—colon cancer	0.000177	0.000523	CbGpPWpGaD
Glycine—GSS—Metabolism—ABCB1—colon cancer	0.000175	0.000519	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PPARG—colon cancer	0.000175	0.000518	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—HRAS—colon cancer	0.000175	0.000517	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—HRAS—colon cancer	0.000174	0.000515	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—BRAF—colon cancer	0.000173	0.000512	CbGpPWpGaD
Glycine—GSS—Metabolism—TYMS—colon cancer	0.000172	0.00051	CbGpPWpGaD
Glycine—SHMT1—Disease—FGFR3—colon cancer	0.000169	0.000499	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—EGFR—colon cancer	0.000168	0.000496	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTGS2—colon cancer	0.000167	0.000495	CbGpPWpGaD
Glycine—GATM—Metabolism—PTGS2—colon cancer	0.000167	0.000495	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTGS2—colon cancer	0.000167	0.000495	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTGS2—colon cancer	0.000167	0.000495	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—PIK3CA—colon cancer	0.00016	0.000474	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTGS2—colon cancer	0.000159	0.000472	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—KRAS—colon cancer	0.000158	0.000469	CbGpPWpGaD
Glycine—SHMT1—Disease—APC—colon cancer	0.000155	0.000459	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PPARG—colon cancer	0.000153	0.000455	CbGpPWpGaD
Glycine—SHMT1—Disease—BRAF—colon cancer	0.000145	0.000431	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PIK3CA—colon cancer	0.000145	0.000431	CbGpPWpGaD
Glycine—GARS—Gene Expression—AKT1—colon cancer	0.000142	0.000422	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTGS2—colon cancer	0.000142	0.000421	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—EP300—colon cancer	0.000139	0.000411	CbGpPWpGaD
Glycine—GATM—Metabolism—EP300—colon cancer	0.000139	0.000411	CbGpPWpGaD
Glycine—GLYAT—Metabolism—EP300—colon cancer	0.000139	0.000411	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—EP300—colon cancer	0.000139	0.000411	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTGS2—colon cancer	0.000138	0.000407	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3CA—colon cancer	0.000136	0.000402	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—HRAS—colon cancer	0.000135	0.000399	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—HRAS—colon cancer	0.000133	0.000395	CbGpPWpGaD
Glycine—BAAT—Metabolism—EP300—colon cancer	0.000132	0.000393	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—AKT1—colon cancer	0.000131	0.000388	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CASP3—colon cancer	0.00013	0.000384	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCND1—colon cancer	0.000126	0.000374	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PPARG—colon cancer	0.000125	0.000371	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CTNNB1—colon cancer	0.000125	0.00037	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CDKN1A—colon cancer	0.000122	0.000362	CbGpPWpGaD
Glycine—GSS—Metabolism—PPARG—colon cancer	0.000122	0.000361	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTGS2—colon cancer	0.000121	0.000358	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—AKT1—colon cancer	0.000119	0.000352	CbGpPWpGaD
Glycine—AGXT—Metabolism—EP300—colon cancer	0.000118	0.00035	CbGpPWpGaD
Glycine—SHMT1—Disease—PTGS2—colon cancer	0.000118	0.000348	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EP300—colon cancer	0.000116	0.000344	CbGpPWpGaD
Glycine—ALAS1—Metabolism—EP300—colon cancer	0.000114	0.000339	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SRC—colon cancer	0.000113	0.000335	CbGpPWpGaD
Glycine—ALAS2—Metabolism—AKT1—colon cancer	0.000111	0.000328	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—VEGFA—colon cancer	0.00011	0.000326	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NRAS—colon cancer	0.000109	0.000322	CbGpPWpGaD
Glycine—SHMT1—Disease—CTNNB1—colon cancer	0.000105	0.000312	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CA—colon cancer	0.000103	0.000304	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CA—colon cancer	0.000103	0.000304	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CA—colon cancer	0.000103	0.000304	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CA—colon cancer	0.000103	0.000304	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN1A—colon cancer	0.000103	0.000304	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MYC—colon cancer	0.000101	0.0003	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TGFB1—colon cancer	0.000101	0.000299	CbGpPWpGaD
Glycine—AGXT2—Metabolism—EP300—colon cancer	0.0001	0.000297	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EGFR—colon cancer	9.9e-05	0.000293	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTGS2—colon cancer	9.84e-05	0.000292	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CA—colon cancer	9.8e-05	0.00029	CbGpPWpGaD
Glycine—SHMT1—Disease—EP300—colon cancer	9.77e-05	0.00029	CbGpPWpGaD
Glycine—GSS—Metabolism—PTGS2—colon cancer	9.59e-05	0.000284	CbGpPWpGaD
Glycine—SHMT1—Disease—SRC—colon cancer	9.5e-05	0.000282	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KRAS—colon cancer	9.35e-05	0.000277	CbGpPWpGaD
Glycine—SHMT1—Disease—NRAS—colon cancer	9.14e-05	0.000271	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CA—colon cancer	8.74e-05	0.000259	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CA—colon cancer	8.59e-05	0.000255	CbGpPWpGaD
Glycine—SHMT1—Disease—MYC—colon cancer	8.52e-05	0.000252	CbGpPWpGaD
Glycine—SHMT1—Disease—TGFB1—colon cancer	8.5e-05	0.000252	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CA—colon cancer	8.46e-05	0.000251	CbGpPWpGaD
Glycine—GATM—Metabolism—AKT1—colon cancer	8.39e-05	0.000249	CbGpPWpGaD
Glycine—GLYAT—Metabolism—AKT1—colon cancer	8.39e-05	0.000249	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—AKT1—colon cancer	8.39e-05	0.000249	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—AKT1—colon cancer	8.39e-05	0.000249	CbGpPWpGaD
Glycine—SHMT1—Disease—EGFR—colon cancer	8.33e-05	0.000247	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TP53—colon cancer	8.31e-05	0.000246	CbGpPWpGaD
Glycine—SHMT1—Metabolism—EP300—colon cancer	8.19e-05	0.000243	CbGpPWpGaD
Glycine—BAAT—Metabolism—AKT1—colon cancer	8.01e-05	0.000237	CbGpPWpGaD
Glycine—GSS—Metabolism—EP300—colon cancer	7.98e-05	0.000236	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HRAS—colon cancer	7.95e-05	0.000235	CbGpPWpGaD
Glycine—SHMT1—Disease—KRAS—colon cancer	7.87e-05	0.000233	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CA—colon cancer	7.43e-05	0.00022	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CA—colon cancer	7.23e-05	0.000214	CbGpPWpGaD
Glycine—AGXT—Metabolism—AKT1—colon cancer	7.14e-05	0.000211	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKT1—colon cancer	7.02e-05	0.000208	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AKT1—colon cancer	6.91e-05	0.000205	CbGpPWpGaD
Glycine—SHMT1—Disease—HRAS—colon cancer	6.69e-05	0.000198	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AKT1—colon cancer	6.07e-05	0.00018	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CA—colon cancer	6.06e-05	0.000179	CbGpPWpGaD
Glycine—SHMT1—Disease—AKT1—colon cancer	5.91e-05	0.000175	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CA—colon cancer	5.9e-05	0.000175	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AKT1—colon cancer	4.95e-05	0.000147	CbGpPWpGaD
Glycine—GSS—Metabolism—AKT1—colon cancer	4.82e-05	0.000143	CbGpPWpGaD
